Is Aviva plc The Best Insurer In The UK?

Aviva plc (LON:AV) is not an easy call, but is very possibly one of the safest bet in the insurance sector, argues this Fool.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Is Aviva (LSE: AV) (NYSE: AV.US) the best play in the insurance sector right now?

Well, the rise in its stock price in recent weeks poses more questions than answers, in my view. There are signs that Aviva stock may be overvalued, although Aviva’s fundamentals and prospects aren’t too bad.aviva And how about RSA Insurance (LSE: RSA), Legal & General (LSE: LGEN) and Admiral (LSE: ADM)? Do their valuations offer an attractive entry point for investors looking for bargains?

Aviva: Time To Cash In?

Fact: On August 7, I argued that Aviva was “a risky investment proposition”, but I also noted that its shares were not too expensive, and may have been added to a diversified portfolio. “I may cash in a 10% pre-tax paper gain,” I pointed out. Aviva stock has risen by about 4% over the period. If I were invested, I would be tempted to cash in right now. Not so fast.

What’s going on: Aviva has certainly struggled to create value for shareholders since the credit crunch, yet things have markedly improved in the last year or so. This life and general insurance business, which has a market cap of £15.4bn, may have turned the corner. Rivals’ woes are a blessing for Aviva shareholders. Of course, Aviva still bears the hallmarks of a restructuring story, given that it must continue to cut costs to improve its cash flows and earnings. Projections for muted revenue growth are priced into its trading multiples, in my opinion.

Upside: A back-of-the-envelope valuation suggests that Aviva stock could reward shareholders. Upside could be as much as 15% to the end of the year, under a bull-case scenario — or just 5%, under a base-case scenario. Downside risk is about 5% to the end of 2014.

RSA, L&G And Admiral: All In the Same Boat?

L&G stock is hovering around all-time highs. It’s expensive based on trading multiples, in my view. Dividends and earnings are expected to grow nicely until the end of 2016, but such estimates in the insurance sector are just that — estimates. L&G stock carries a 10% downside to the end of the year, although I like its business model and its management team. L&G remains a better investment proposition than RSA and Admiral.

“Chief Executive Kevin Chidwick and Chief Financial Officer Geriant Jones were awarded 114 shares each under its share incentive plan at a strike price of £13.064 per share,” Admiral said on Monday. The stock traded just below £13 on Tuesday, but it is down more than 4% on Wednesday. It trades about 20% below the high in recorded in July.

Interested? Admiral stock is for opportunistic traders, rather than for value investors. End of the story. RSA, meanwhile, isn’t exactly the safest restructuring story in the sector. So, forget about it for the time being.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »